Homozygous familial hypercholesterolaemia: shedding new light on a rare but deadly condition

被引：3
作者：
Banach, Maciej [1 ,2 ]
Penson, Peter E. [3 ,4 ]
机构：
[1] Med Univ Lodz MUL, Dept Prevent Cardiol & Lipidol, Lodz, Poland
[2] Univ Zielona Gora, Cardiovasc Res Ctr, Zielona Gora, Poland
[3] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Clin Pharm & Therapeut Res Grp, Liverpool, Merseyside, England
[4] Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2022年 / 29卷 / 05期
关键词：
LIPID DISORDERS; POSITION PAPER; THERAPY; RISK;
D O I：
10.1093/eurjpc/zwac032
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：815 / 816
页数：2
相关论文
共 13 条
  • [1] PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
    Banach, Maciej
    Burchardt, Pawl
    Chlebus, Krzysztof
    Dobrowolski, Piotr
    Dudek, Dariusz
    Dyrbus, Krzysztof
    Gasior, Mariusz
    Jankowski, Piotr
    Jozwiak, Jacek
    Klosiewicz-Latoszek, Longina
    Kowalska, Irina
    Malecki, Maciej
    Prejbisz, Aleksander
    Rakowski, Michat
    Rysz, Jacek
    Solnica, Bogdan
    Sitkiewicz, Dariusz
    Sygitowicz, Grazyna
    Sypniewska, Grazyna
    Tomasik, Tomasz
    Windak, Adam
    Zozulinska-Ziolkiewicz, Dorota
    Cybulska, Barbara
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (06) : 1447 - 1547
  • [2] Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)
    Banach, Maciej
    Penson, Peter E.
    Vrablik, Michal
    Bunc, Matjaz
    Dyrbus, Krzysztof
    Fedacko, Jan
    Gaita, Dan
    Gierlotka, Marek
    Jarai, Zoltan
    Magda, Stefania Lucia
    Margetic, Eduard
    Margoczy, Roman
    Durak-Nalbantic, Azra
    Ostadal, Petr
    Pella, Daniel
    Trbusic, Matias
    Udroiu, Cristian Alexandru
    Vlachopoulos, Charalambos
    Vulic, Dusko
    Fras, Zlatko
    Dudek, Dariusz
    Reiner, Zeljko
    [J]. PHARMACOLOGICAL RESEARCH, 2021, 166
  • [3] Cellular senescence, telomeres, and cardiovascular risk in familial hypercholesterolaemia
    Banach, Maciej
    Penson, Peter E.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (05) : 718 - 720
  • [4] Genetic testing in familial hypercholesterolaemia: What does it add?
    Banach, Maciej
    Penson, Peter E.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (01) : 105 - 106
  • [5] What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER?
    Banach, Maciej
    Penson, Peter E.
    [J]. CARDIOVASCULAR RESEARCH, 2019, 115 (03) : E26 - E31
  • [6] Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert Panel
    Bjelakovic, Bojko
    Stefanutti, Claudia
    Reiner, Zeljko
    Watts, Gerald F.
    Moriarty, Patrick
    Marais, David
    Widhalm, Kurt
    Cohen, Hofit
    Harada-Shiba, Mariko
    Banach, Maciej
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [7] Doyle A.C, 1892, ADVENTURES SHERLOCK
  • [8] RNA Silencing in the Management of Dyslipidemias
    Henney, Neil C.
    Banach, Maciej
    Penson, Peter E.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (11)
  • [9] Major adverse cardiovascular events in homozygous familial hypercholesterolaemia: a systematic review and meta-analysis
    Kramer, Adam, I
    Akioyamen, Leo E.
    Lee, Seohyuk
    Belanger, Alexandre
    Ruel, Isabelle
    Hales, Lindsay
    Genest, Jacques
    Brunham, Liam R.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (05) : 817 - 828
  • [10] RETRACTED: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis (Retracted article. See vol. 21, 2023)
    Momtazi-Borojeni, Amir Abbas
    Jaafari, Mahmoud Reza
    Badiee, Ali
    Banach, Maciej
    Sahebkar, Amirhossein
    [J]. BMC MEDICINE, 2019, 17 (01)
12